ClinicalTrials.gg
RecruitingNCT05414513Updated Jun 1, 2023

The Turkish Fear of Pain Questionnaire

An observational study in Chronic Headache, sponsored by Akdeniz University. Recruiting at 1 site in Turkey. Open to participants aged 5 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-01.

Sponsored by Akdeniz University · Observational

From the registry’s dates

  • Primary completion was expected by Aug 2023, 3 years 3 months ago, but the record still lists the study as recruiting.
  • Started Sep 2022; still recruiting 4 years 2 months later.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
195
Ages
5 Years to 18 Years
Sex
All
01

Study summary

Children's chronic pain is a significant condition that affects roughly 25% of children, with approximately 3% of them requiring intense pain therapy. In the adult literature, various scales have been established to assess fear of pain. When these scales are studied, fear of pain has been shown to have a role in adult chronic pain research, but this topic has gotten less attention in pediatric chronic pain research. The Fear of Pain Questionnaire for Children (FOPQ-C) is a questionnaire that addresses this knowledge gap. The purpose of this study is to determine the validity and clinical utility of the Fear of Pain Questionnaire for Children (FOPQ-C) Scale in the Turkish community.

Read the detailed description

Pain is a multidimensional experience that includes sensory, cognitive, emotional, and social factors. The International Association for the Study of Pain defines chronic pain as pain that lasts longer than three months, besides the lack of a clear description. Chronic pain is a critical developmental health issue that can be recurring or persistent, causing significant disruption in everyday life. Children with chronic pain that is continuous or recurrent may be unable to attend school, may withdraw from social activities, and may develop internalizing symptoms as a result of their discomfort. Given these findings, researchers and clinicians must focus on concerns connected to pediatric chronic pain in order to reduce these challenges and develop appropriate methods. Adults are reported to suffer from 19 percent of chronic pain, with two-thirds describing their pain as "persistent" and 50% describing it as "unbearable." Chronic pain has emerged as a significant problem in children, affecting around one out of every four children, while approximately 3% of children require intense pain therapy.

Psychosocial factors interact with physiological processes to influence pain outcomes such as pain perception and impairment, according to the biopsychosocial model of chronic pain. Fear of pain is a psychological mechanism that has been shown to be effective in predicting chronic pain and accompanying disability in adults. When pain-related sensations are viewed as dangerous, fear of pain develops. The Fear Avoidance Model of Pain outlines how fear of pain influences the outcomes of people who are in chronic pain. Many elements of the condition, including experimentally generated pain severity, pain during dental treatment, chronic pain behavior, and pain-related disability, have been linked to fear of pain. Simultaneously, in the Fear Avoidance Model of Pain, if pain is seen as threatening, pain-related fear develops, leading to avoidance. Simultaneously, in the Fear Avoidance Model of Pain, if pain is seen as threatening, pain-related fear develops, leading to avoidance behaviors and hypervigilance. After that, there's incapacity and depression. These negative outcomes aggravate the fear and avoidance loop. While assessing fear of pain is critical, assessing fear of re-injury is more difficult because it can entail movement, physical activity, or a mix of these things. Furthermore, patients frequently do not report or subjectively sense pain, but rather have trouble performing the actions or activities that have been required of them.

In the adult literature, various scales have been established to assess fear of pain. Fear of pain has been shown to have a role in adult chronic pain research, but it has gotten less attention in pediatric chronic pain research. The Fear of Pain Questionnaire for children and parents (FOPQ-C SF, FOPQ-P) is a questionnaire that addresses this knowledge gap. As a result, the purpose of this study is to see if the Fear of Pain Questionnaire for Children \& Parents (FOPQ-C, FOPQ-P) Scale is valid in the Turkish community and how effective it is in therapeutic practice.

02

Conditions studied

  • Chronic Headache

Browse trials for

Keywords

  • Chronic headache
  • Pain related fear
  • Assessment
  • Children
  • validity
  • cultural adaptation
03

In context

Headache Disorders

145 studies on the registry are indexed under Headache Disorders; 37 are open to participants now.

This study's planned enrollment of 195 is above the median of 131 across 46 observational studies indexed under Headache Disorders.

Browse Headache Disorders studies →

Lead sponsor

Akdeniz University is the lead sponsor of 297 studies on the registry; 62 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Children with chronic pain at aged 5-18 years and their parents, their health peers without chronic pain and their parents

Eligibility criteria

Inclusion criteria of children with chronic pain:

(1) Being diagnosed with chronic pain. (2) To have the cognitive ability to answer questions for assessment. (3) Completing the test-retest assessment. (4) To be the native language Turkish.

  • Exclusion criteria for children with chronic pain:

    1. Uncontrollable psychological diseases (eg, attention deficit hyperactivity disorder, autism spectrum disorder, schizophrenia, bipolar disorder, major depressive disorder), specific pathologies, will not be included in the study.
    2. Patients who started a new treatment during the study or 6 weeks before the study.
    3. Study participants will be instructed not to take analgesics for 48 hours prior to assessments.

Inclusion criteria for healthy children:

  1. between the ages of 5-18.
  2. Not having any psychiatric or neurological diagnosis.
  3. To be the native language Turkish.

Exclusion criteria for healthy children:

  1. Families and children who did not agree to participate in the study.
  2. To have received medical treatment for any neuropsychiatric disorder.
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
195 participants (estimated)
Patient registry
No

Groups and cohorts

  • Chronic Headache Group

    Children with chronic headache

  • Healthy Group

    Children without pain

06

What researchers measure

Primary outcomes

  1. Evaluation of pain of fear for children

    The Fear of Pain Questionnaire-Short Form (FOPQ-C-SF) for Children is a 10-item variant of the 24-item Fear of Pain Questionnaire for Children. It uses children's self-reports to assess pain-related anxieties (4 items) and avoidance behaviors (6 items). When I'm in pain, for example, I cancel my plans. When I'm in pain, I'm worried something bad may happen. A 0-4 Likert scale is used for scoring. A score of 0 indicates significant disagreement, while a score of 5 indicates great agreement. The total score is calculated by aggregating the individual item scores. Higher pain-related fear and avoidance behavior are associated with higher scores.

    Time frame: Baseline

  2. Evaluation of pain of fear for parents

    The Fear of Pain Scale for Children-Parent Form (FOPQ-P) is a scale that evaluates children's fear of pain with a parent report. FOPQ-P consists of 23 items. The scale assesses fear of pain in three sub-areas. These are: Fear of Pain (8 items), Avoidance of Activities (10 items), and Avoidance of School (5 items). Scoring is done on a Likert scale of 0-4 points. The parent rates the child's approach to pain that has existed for several hours or throughout the day, from 0 = strongly disagree to 4 = strongly agree.

    Time frame: Baseline

Secondary outcomes

  1. Evaluation of pain catastrophing for children

    The Pain Catastrophing Scale was developed to assess adults' pain-related catastrophizing thoughts. The Pain Catastrophizing Scale-Child (PCS-C) is an adapted version of the Pain Catastrophizing Scale for children. PCS-C evaluates catastrophizing behavior with 13 items: thinking long about pain (4 items), magnifying pain (3 items), and helplessness (6 items). For example, I can't get the pain out of my mind. I'm afraid my pain will get worse. There is nothing I can do to reduce the pain. Scoring is done on a Likert scale of 0-4 points. 0=not at all; 4=extremely The adult version of the Turkish version of the Pain Catastrophizing Scale for families will be used.

    Time frame: Baseline

  2. Evaluation of pain for children

    It is a valid and reliable scale that children and their families prefer to use when determining the level of discomfort. It is made up of six different facial expressions that represent the degree of pain. From a happy face (0 points) to a very sad and crying expression, they show the stages of increasing pain (10 points). Each facial expression's meaning is carefully explained to the child. The severity of pain during facials is rated by children.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Palermo TM, Chambers CT. Parent and family factors in pediatric chronic pain and disability: an integrative approach. Pain. 2005 Dec 15;119(1-3):1-4. doi: 10.1016/j.pain.2005.10.027. Epub 2005 Nov 18. No abstract available. PubMed 16298492 ↗
  • Palermo TM. Impact of recurrent and chronic pain on child and family daily functioning: a critical review of the literature. J Dev Behav Pediatr. 2000 Feb;21(1):58-69. doi: 10.1097/00004703-200002000-00011. PubMed 10706352 ↗
  • King S, Chambers CT, Huguet A, MacNevin RC, McGrath PJ, Parker L, MacDonald AJ. The epidemiology of chronic pain in children and adolescents revisited: a systematic review. Pain. 2011 Dec;152(12):2729-2738. doi: 10.1016/j.pain.2011.07.016. PubMed 22078064 ↗
  • Jiao J, Vincent A, Cha SS, Luedtke CA, Kim CH, Oh TH. Physical Trauma and Infection as Precipitating Factors in Patients with Fibromyalgia. Am J Phys Med Rehabil. 2015 Dec;94(12):1075-82. doi: 10.1097/PHM.0000000000000300. PubMed 25888651 ↗
  • Hechler T, Dobe M, Zernikow B. Commentary: A worldwide call for multimodal inpatient treatment for children and adolescents suffering from chronic pain and pain-related disability. J Pediatr Psychol. 2010 Mar;35(2):138-40. doi: 10.1093/jpepsy/jsp066. Epub 2009 Aug 14. No abstract available. PubMed 19684118 ↗
  • Leeuw M, Goossens ME, Linton SJ, Crombez G, Boersma K, Vlaeyen JW. The fear-avoidance model of musculoskeletal pain: current state of scientific evidence. J Behav Med. 2007 Feb;30(1):77-94. doi: 10.1007/s10865-006-9085-0. Epub 2006 Dec 20. PubMed 17180640 ↗
  • Vlaeyen JWS, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain. 2000 Apr;85(3):317-332. doi: 10.1016/S0304-3959(99)00242-0. PubMed 10781906 ↗
  • Berniger Romariz JA, Nonnemacher C, Abreu M, Dickel Segabinazi J, Bandeira JS, Beltran G, Souza A, Torres IL, Caumo W. The Fear of Pain Questionnaire: psychometric properties of a Brazilian version for adolescents and its relationship with brain-derived neurotrophic factor (BDNF). J Pain Res. 2019 Aug 7;12:2487-2502. doi: 10.2147/JPR.S199120. eCollection 2019. PubMed 31496790 ↗

Individual participant data

Plan to share: No — The results are going to publish the journal

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05414513
Lead sponsor
Akdeniz University
Responsible party
Ozgun Kaya Kara (Assoc. Prof. PhD, Akdeniz University) — Principal investigator
First posted
Jun 10, 2022
Start date
Sep 8, 2022
Primary completion
Aug 8, 2023 (estimated)
Completion
Aug 12, 2023 (estimated)
Last update
Jun 1, 2023

Study contacts

Ishak Isik, MD
Contact
etik.kurul.07@gmail.com
02422494400
Ozgun Kaya Kara, Assoc. Prof
study director · Akdeniz University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion